Literature DB >> 1389725

Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.

S C Grant.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389725      PMCID: PMC1024867          DOI: 10.1136/hrt.67.5.419-a

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  7 in total

1.  Thrombolytic treatment for recurrent myocardial infarction.

Authors:  H White
Journal:  BMJ       Date:  1991-02-23

2.  Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking.

Authors:  J T Rivers; H D White; D B Cross; B F Williams; R M Norris
Journal:  J Am Coll Cardiol       Date:  1990-08       Impact factor: 24.094

3.  Antistreptokinase titres after intravenous streptokinase.

Authors:  S Jalihal; G K Morris
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

4.  Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.

Authors:  H D White; D B Cross; B F Williams; R M Norris
Journal:  Br Heart J       Date:  1990-09

5.  Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.

Authors:  E M Ohman; R M Califf; E J Topol; R Candela; C Abbottsmith; S Ellis; K N Sigmon; D Kereiakes; B George; R Stack
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

6.  Assessment of anti-streptokinase antibody levels in human sera using a microradioimmunoassay procedure.

Authors:  D M Moran; R Standring; E A Lavender; G S Harris
Journal:  Thromb Haemost       Date:  1984-12-29       Impact factor: 5.249

7.  Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.

Authors:  M Lynch; W A Littler; B L Pentecost; R A Stockley
Journal:  Br Heart J       Date:  1991-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.